Full Text
Cost-Effectiveness Analysis of Daclatasvir in Combination with Asunaprevir (DUAL) for the Treatment of Chronic Hepatitis C Patients in China

Abstract

Authors

W CHENG W Chen

Back to Volume 21, Supplemental S1
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×